Uric acid

Uric acid
Uric acid.png
Uric acid3D.png
IUPAC name 7,9-dihydro-1H-purine-
2,6,8(3H)-trione
Other names 2,6,8 Trioxypurine
Identifiers
CAS number 69-93-2
PubChem 1175
EINECS number 200-720-7
KEGG C00366
SMILES
InChI
ChemSpider ID 1142
Properties
Molecular formula C5H4N4O3
Molar mass 168g/mol
Appearance White Crystals
Density 1.87
Melting point

decomposes on heating

Boiling point

N/A

Solubility in water Slightly
Acidity (pKa) 3.89
Except where noted otherwise, data are given for
materials in their standard state
(at 25 °C, 100 kPa)
Infobox references

Uric acid (or urate) is an organic compound of carbon, nitrogen, oxygen and hydrogen with the formula C5H4N4O3.

Contents

Metabolic processes

Uric acid is a breakdown product of DNA & RNA, converted by xanthine oxidase from xanthine and hypoxanthine, which are in turn purine breakdown products. Uric acid is more toxic to tissues than either xanthine or hypoxanthine.

Xanthine oxidase oxidizes oxypurines such as xanthine and hypoxanthine to uric acid. In humans and higher primates, uric acid is the final oxidation product of purine catabolism. In most other mammals, the enzyme uricase further oxidizes uric acid to allantoin.[2] The loss of uricase in higher primates parallels the similar loss of the ability to synthesize ascorbic acid.[3] Both urate and ascorbate are strong reducing agents (electron donors) and potent antioxidants. In humans, over half the antioxidant capacity of plasma comes from uric acid.

Uric acid is also the end product of nitrogen catabolism in birds and reptiles. In such species, it is excreted in feces as a dry mass. While this compound is produced through a complex and energetically costly metabolic pathway (in comparison to other nitrogenated wastes such as urea or ammonia), its elimination minimizes water loss. It is therefore commonly found in the excretions of animals—such as the kangaroo rat—that live in very dry environments. The Dalmatian dog has a defect in uric acid uptake by liver, resulting in decreased conversion to allantoin, so this breed excretes uric acid, and not allantoin, in the urine.

Medical issues

Humans produce large quantities of uric acid. In human blood plasma, the reference range of uric acid is between 3.6 mg/dL (~214µmol/L) and 8.3 mg/dL (~494µmol/L) (1mg/dL=59.48 µmol/L).[4] This range is considered normal by the American Medical Association, although significantly lower levels are common in vegetarians due to a decreased intake of purine-rich meat.[5] Uric acid concentrations in blood plasma above and below the normal range are known, respectively, as hyperuricemia and hypouricemia. Similarly, uric acid concentrations in urine above and below normal are hyperuricosuria and hypouricosuria. Each of these conditions has a variety of causes and consequences.

Reference ranges for blood tests, comparing blood content of uric acid (shown in green) with other constituents.
Shown in molarity rather than mass. Uric acid shown in yellow.

High uric acid

Gout

Excess serum accumulation of uric acid can lead to a type of arthritis known as gout.[6]

Elevated serum uric acid (hyperuricemia) can result from high intake of purine-rich foods, high fructose intake (regardless of fructose's low Glycemic Index (GI) value) and/or impaired excretion by the kidneys. Saturation levels of uric acid in blood may result in one form of kidney stones when the urate crystallizes in the kidney. These uric acid stones are radiolucent and so do not appear on an abdominal x-ray. Their presence must be diagnosed by ultrasound for this reason. Some patients with gout eventually get uric kidney stones.

Gout can occur where serum uric acid levels are as low as 6 mg/dL (~357µmol/L), but an individual can have serum values as high as 9.5 mg/dL (~565µmol/L) and not have gout[7] (no abstract available; levels reported at [8]).

Lesch-Nyhan syndrome

Lesch-Nyhan syndrome, an extremely rare inherited disorder, is also associated with very high serum uric acid levels.[9]

Spasticity, involuntary movement and cognitive retardation as well as manifestations of gout are seen in cases of this syndrome.[10]

Cardiovascular disease

Although uric acid can act as an antioxidant, excess serum accumulation is often associated with cardiovascular disease. It is not known whether this is causative (e.g., by acting as a prooxidant ) or a protective reaction taking advantage of urate's antioxidant properties. [11]

Diabetes

The association of high serum uric acid with insulin resistance has been known since the early part of the 20th century, nevertheless, recognition of high serum uric acid as a risk factor for diabetes has been a matter of debate. In fact, hyperuricemia has always been presumed to be a consequence of insulin resistance rather than its precursor [12]. However, it was shown in a prospective follow-up study that high serum uric acid is associated with higher risk of type 2 diabetes independent of obesity, dyslipidemia, and hypertension [13].

Metabolic syndrome

Hyperuricemia is associated with components of metabolic syndrome and it has been debated for a while to be a component of it. It has been shown in a recent study that fructose-induced hyperuricemia may play a pathogenic role in the metabolic syndrome. This agrees with the increased consumption of fructose-base drinks in recent decades and the epidemic of diabetes and obesity [14].

Uric Acid Stone Formation

Uric acid stones, which form in the absence of secondary causes such as chronic diarrhea, vigorous exercise, dehydration, and animal protein loading, are felt to be secondary to obesity and insulin resistance seen in metabolic syndrome. Increased dietary acid leads to increased endogenous acid production in the liver and muscles which in turn leads to an increased acid load to the kidneys. This load is handled more poorly because of renal fat infiltration and insulin resistance which are felt to impair ammonia excretion (a buffer). The urine is therefore quite acidic and uric acid becomes insoluble, crystallizes and stones form. In addition, naturally present promoter and inhibitor factors may be affected. This explains the the high prevalence of uric stones and unusually acid urine seen in patients with Type II diabetes. Uric acid crystals can also promote the formation of calcium oxalate stones, acting as "seed crystals" (heterogenous nucleation).[15]

Low uric acid

Multiple sclerosis

Lower serum values of uric acid have been associated with Multiple Sclerosis. Multiple sclerosis (MS) patients have been found to have serum levels ~194µmol/L, with patients in relapse averaging ~160µmol/L and patients in remission averaging ~230µmol/L. Serum uric acid in healthy controls was ~290µmol/L.[16] Conversion factor: 1mg/dL=59.48 µmol/L[17]

A 1998 study completed a statistical analysis of 20 million patient records, comparing serum uric acid values in patients with gout and patients with multiple sclerosis. Almost no overlap between the groups was found.[18]

Uric acid has been successfully used in the treatment and prevention of the animal (murine) model of MS. A 2006 study found that elevation of serum uric acid values in multiple sclerosis patients, by oral supplementation with inosine, resulted in lower relapse rates, and no adverse effects.[19]

Oxidative stress

Uric acid may be a marker of oxidative stress,[20] and may have a potential therapeutic role as an antioxidant.[21] On the other hand, like other strong reducing substances such as ascorbate, uric acid can also act as a prooxidant,[22] particularly at elevated levels. Thus, it is unclear whether elevated levels of uric acid in diseases associated with oxidative stress such as stroke and atherosclerosis are a protective response or a primary cause.[23]

For example, some researchers propose that hyperuricemia-induced oxidative stress is a cause of Metabolic syndrome.[24][25] On the other hand, plasma uric acid levels correlate with longevity in primates and other mammals.[26] This is presumably a function of urate's antioxidant properties.

Sources of uric acid

Causes of low uric acid

Low uric acid (hypouricemia) has numerous causes.

Sevelamer, a drug indicated for prevention of hyperphosphataemia in patients with chronic renal failure, can significantly reduce serum uric acid.[31]

Other uric acid facts

The high nitrogen content of uric acid makes guano a useful agricultural fertilizer.

The crystalline form of uric acid is used as a reflector in certain species of fireflies.

The uric acid in urine can also dry in a baby's diaper to form a pinkish powder that is harmless.

See also

External links

References

  1. "Uric Acid." Biological Magnetic Resonance Data Bank. Indicator Information Retrieved on 18 February 2008.
  2. Purine and Pyrimidine Metabolism
  3. Proctor, P. (1970). "Similar Functions of Uric Acid and Ascorbate in Man". Nature 228: 868. doi:10.1038/228868a0. http://www.ncbi.nlm.nih.gov/pubmed/5477017. 
  4. SI Units for Clinical Data
  5. Siener R, Hesse A. (2003). "The effect of a vegetarian and different omnivorous diets on urinary risk factors for uric acid stone formation". Eur J Nutr 42(6): 332–7. doi:10.1007/s00394-003-0428-0. http://www.ncbi.nlm.nih.gov/pubmed/14673606. 
  6. Tausche AK et al. (2006). "Hyperuricemia and gout: diagnosis and therapy. Article in German". Internist (Berl). 47(5): 509–20. doi:10.1007/s00108-006-1578-y. http://www.ncbi.nlm.nih.gov/pubmed/17190309. 
  7. Laster L, Howell RR. (1963). "Biochemistry of uric acid and its relation to gout". N Engl J Med 268: 764–73. http://www.ncbi.nlm.nih.gov/pubmed/16586130. 
  8. Uric Acid, Serum
  9. Luo YC et al. (2006). "An amperometric uric acid biosensor based on modified Ir-C electrode". Biosens Bioelectron 22(4): 482–8. doi:10.1016/j.bios.2006.07.013. http://www.ncbi.nlm.nih.gov/pubmed/16908130. 
  10. Nyhan WL (2005). "Lesch-Nyhan Disease". J Hist Neurosci 14(1): 1–10. doi:10.1080/096470490512490. http://www.ncbi.nlm.nih.gov/pubmed/15804753. 
  11. Heinig M, Johnson RJ. (2006). "Role of uric acid in hypertension, renal disease, and metabolic syndrome". Cleve Clin J Med. 73(12): 1059–64. http://www.ncbi.nlm.nih.gov/pubmed/17190309. 
  12. Cappuccio FP, et al (1993). "Uric acid metabolism and tubular sodium handling. Results from a population-based study". Jama 270 (3): 354–359. doi:10.1001/jama.270.3.354. PMID 8315780. http://www.ncbi.nlm.nih.gov/pubmed/8315780. 
  13. Dehghan A. et al (2007). "High serum uric acid as a novel risk factor for type 2 diabetes mellitus". Diabetes Care 31: 361. doi:10.2337/dc07-1276. PMID 17977935. http://www.ncbi.nlm.nih.gov/pubmed/17977935. 
  14. Nakagawa T, Hu H, Zharikov S, et al. (2006). "A causal role for uric acid in fructose-induced metabolic syndrome". Am J Physiol Renal Physiol. 290 (3): F625–631. http://www.ncbi.nlm.nih.gov/pubmed/16234313. 
  15. Charles Y.C. Pak (2008). "Metabolic Stone Management: 35 Years of Advances.". Journal of Urology 180 pages = 813-819. 
  16. Toncev G, et al. (2002). "Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction". Eur J Neurol. 9(3): 221–6. doi:10.1046/j.1468-1331.2002.00384.x. http://www.ncbi.nlm.nih.gov/pubmed/11985629. 
  17. SI Units for Clinical Data
  18. Hooper DC, et al. (1998). "Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis". Proc Natl Acad Sci U S A. 95(2): 675–80. doi:10.1073/pnas.95.2.675. PMID 9435251. http://www.ncbi.nlm.nih.gov/pubmed/9435251. 
  19. Toncev G (2006). "Therapeutic value of serum uric acid levels increasing in the treatment of multiple sclerosis". Vojnosanit Pregl. 63(10): 879–82. http://www.ncbi.nlm.nih.gov/pubmed/17121380. 
  20. Becker BF (June 1993). "Towards the physiological function of uric acid". Free radical biology & medicine 14 (6): 615–31. PMID 8325534. http://linkinghub.elsevier.com/retrieve/pii/0891-5849(93)90143-I. 
  21. Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA (2005). "Uric acid and oxidative stress". Current pharmaceutical design 11 (32): 4145–51. PMID 16375736. http://www.bentham-direct.org/pages/content.php?CPD/2005/00000011/00000032/0006B.SGM. 
  22. Proctor P. (1972). "Electron-transfer factors in psychosis and dyskinesia". Physiol Chem Phys. 4(4): 349–60. http://www.ncbi.nlm.nih.gov/pubmed/4680784. 
  23. Free Radicals and Human Disease
  24. Nakagawa T, et al (2006). "A causal role for uric acid in fructose-induced metabolic syndrome". Am J Physiol Renal Physiol. 290(3): F625–31. http://www.ncbi.nlm.nih.gov/pubmed/16234313. 
  25. Hayden MR, Tyagi SC. (2004). "Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle". Nutr Metab. 1(1): 10. doi:10.1186/1743-7075-1-10. http://www.ncbi.nlm.nih.gov/pubmed/15507132. 
  26. Cutler RG. (1984). "Urate and ascorbate: their possible roles as antioxidants in determining longevity of mammalian species". Arch Gerontol Geriatr. 3(4): 321–48. doi:10.1016/0167-4943(84)90033-5. http://www.ncbi.nlm.nih.gov/pubmed/6532339. 
  27. Gout Causes: List of Diet/Food Sources High or Low in Purine Content
  28. Gout Diet / Low Purine Diet - Limit High Purine foods
  29. Choi HK, et al. (2004). "Purine-rich foods, dairy and protein intake, and the risk of gout in men". N Engl J Med. 350(11): 1093–103. doi:10.1056/NEJMoa035700. PMID 15014182. http://www.ncbi.nlm.nih.gov/pubmed/15014182. 
  30. Nakagawa T, et al (2006). "A causal role for uric acid in fructose-induced metabolic syndrome". Am J Physiol Renal Physiol. 290(3): F625–31. http://www.ncbi.nlm.nih.gov/pubmed/16234313. 
  31. Garg JP, Chasan-Taber S, Blair A, et al (January 2005). "Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: a randomized clinical trial". Arthritis and rheumatism 52 (1): 290–5. doi:10.1002/art.20781. PMID 15641045.